Top 10 Value Stocks To Buy For 2019

The big day is rapidly approaching. In just over a month, on Oct. 17, recreational marijuana will go on sale in licensed dispensaries throughout Canada. When fully legal, the sale of adult-use weed is expected to usher in high demand and big dollar figures for the industry.

In anticipation of this legalization — and the big profits that are projected to follow — marijuana stock investors and Wall Street have pushed the valuations of many pot stocks into nosebleed territory. Some of these marijuana stocks are still valued modestly below Wall Street’s consensus price target per share. Conversely, there are a handful of top marijuana stocks whose price targets are well below their current share price. Keeping in mind that Wall Street price targets are nothing more than dart throws by analysts, here are three top marijuana stocks that are expected to lose at least a quarter of their value.

Image source: Getty Images.

Top 10 Value Stocks To Buy For 2019: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Logan Wallace]

    State Board of Administration of Florida Retirement System raised its stake in Medifast Inc (NYSE:MED) by 12.4% during the second quarter, HoldingsChannel reports. The institutional investor owned 5,781 shares of the specialty retailer’s stock after buying an additional 640 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Medifast were worth $926,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. The official website for MediBloc [QRC20] is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here. MediBloc [QRC20]’s official message board is medium.com/@MediBloc.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 20 percent to $119 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Ethan Ryder]

    MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 22 percent to $121.06 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Sean Williams]

    Meanwhile, Medifast’s (NYSE:MED) share price has tripled since the beginning of March. Medifast’s second-quarter operating results showcased a 55% increase in sales and an 84% improvement in year-over-year adjusted earnings per share. A substantial increase in Optavia-branded products sold, along with a big jump in active earning coaches, drove results. The company also substantially lifted its full-year sales and profit guidance (close to 20% at the midpoint for both measures). 

Top 10 Value Stocks To Buy For 2019: Hingham Institution for Savings(HIFS)

Advisors’ Opinion:

  • [By Max Byerly]

    Port Capital LLC lifted its stake in Hingham Institution for Savings (NASDAQ:HIFS) by 14.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,159 shares of the savings and loans company’s stock after purchasing an additional 5,943 shares during the quarter. Hingham Institution for Savings accounts for approximately 1.4% of Port Capital LLC’s holdings, making the stock its 25th biggest position. Port Capital LLC owned approximately 2.28% of Hingham Institution for Savings worth $9,921,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Hingham Institution for Savings (NASDAQ:HIFS) and SVB Financial Group (NASDAQ:SIVB) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, earnings, analyst recommendations and dividends.

  • [By Joseph Griffin]

    Epoch Investment Partners Inc. grew its stake in Hingham Institution for Savings (NASDAQ:HIFS) by 71.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 92,261 shares of the savings and loans company’s stock after purchasing an additional 38,440 shares during the quarter. Epoch Investment Partners Inc. owned approximately 4.37% of Hingham Institution for Savings worth $19,006,000 as of its most recent SEC filing.

Top 10 Value Stocks To Buy For 2019: lululemon athletica inc.(LULU)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos, Jeremy Bowman, and Steve Symington]

    With that in mind, Motley Fool investors scoured the industry for examples of retailers that boast attractive long-run growth opportunities. Read on to find out why Five Below (NASDAQ:FIVE), lululemon (NASDAQ:LULU), and Boot Barn (NYSE:BOOT) topped that list. 

  • [By Jeremy Bowman]

    Meanwhile, Under Armour’s rivals like Nike (NYSE:NKE), Adidas (NasdaqOTC: ADDYY), and lululemon athletica (NASDAQ:LULU) all performed well in the survey. Piper Jaffray found that Adidas was the fastest-growing brand in the survey, which follows Adidas’s recent stock surge and sales and profit growth. Its Originals, or classic sneakers, like the Stan Smith and the Superstar were especially popular last year. The Superstar, in fact, was the No. 1-selling sneaker last year, according to NPD Group, dethroning Nike for the first time in more than a decade.  

  • [By John Ballard]

    However, Nike’s core business is still selling sneakers. That’s not going to change, and that’s also why lululemon athletica (NASDAQ:LULU) should continue to do fine. Just as Nike has been successful turning a basketball shoe into a fashion statement, Lululemon has accomplished the same in athletic apparel. Both companies are really good at what they do best, and that will protect Lululemon’s competitive position from larger rivals.

Top 10 Value Stocks To Buy For 2019: ATA Inc.(ATAI)

Advisors’ Opinion:

  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Top 10 Value Stocks To Buy For 2019: Amtech Systems Inc.(ASYS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ValuEngine cut shares of Amtech Systems (NASDAQ:ASYS) from a hold rating to a sell rating in a research note published on Wednesday morning.

    Separately, Zacks Investment Research raised Amtech Systems from a sell rating to a hold rating in a research report on Monday, April 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of $14.88.

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Stephan Byrd]

    Brooks Automation (NASDAQ: BRKS) and Amtech Systems (NASDAQ:ASYS) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

  • [By Stephan Byrd]

    SUMITOMO HEAVY/ADR (NASDAQ: ASYS) and Amtech Systems (NASDAQ:ASYS) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Top 10 Value Stocks To Buy For 2019: Imprimis Pharmaceuticals, Inc.(IMMY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Stephan Byrd]

    Headlines about Imprimis Pharmaceuticals (NASDAQ:IMMY) have been trending positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imprimis Pharmaceuticals earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave media headlines about the specialty pharmaceutical company an impact score of 47.393314841388 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t

Top 10 Value Stocks To Buy For 2019: Newmont Mining Corporation(NEM)

Advisors’ Opinion:

  • [By Scott Levine]

    In one of the gold industry’s most notable news stories last month, Goldcorp announced that it had entered into a definitive agreement with Newmont Mining (NYSE:NEM) in which Newmont will acquire all outstanding shares of Goldcorp’s common stock in a deal valued at $10 billion. Newmont will acquire each Goldcorp share for 0.3280 of a Newmont share, representing a 17% premium based on the companies’ 20-day volume weighted average share prices. The transaction is expected to close in the second quarter of 2019 and has already been approved by both companies’ boards of directors.

  • [By Trey Thoelcke]

    Newmont Mining Corp. (NYSE: NEM) is scheduled to report its fourth-quarter results before Thursday’s open. The consensus estimates call for EPS of $0.25 and $1.88 billion in revenue. Shares closed at $33.24 on Friday. The consensus price target is $40.00, and the 52-week trading range is $29.06 to $41.98.

  • [By Paul Ausick]

    Just a week ago today, Barrick Gold Corp. (NYSE: GOLD) announced an unsolicited offer to acquire rival miner Newmont Mining Corp. (NYSE: NEM) for $18 billion. The all-stock offer was rejected Monday morning by Newmont’s board of directors in a decision that was entirely predictable. Less predictable, perhaps, was Newmont’s counteroffer of a joint venture between the two firms’ Nevada operations.

  • [By Joseph Griffin]

    Boston Partners boosted its holdings in shares of Newmont Mining Co. (NYSE:NEM) by 4.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,976 shares of the basic materials company’s stock after buying an additional 2,033 shares during the quarter. Boston Partners’ holdings in Newmont Mining were worth $1,992,000 at the end of the most recent quarter.

Top 10 Value Stocks To Buy For 2019: Clearside BioMedical, Inc. (CLSD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Clearside Biomedical, Inc. (NASDAQ: CLSD) was down, falling around 26 percent to $10.775. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.

  • [By Chris Lange]

    Clearside Biomedical Inc. (NASDAQ: CLSD) shares dropped early on Thursday after the company released data from its midstage clinical trial for diabetic macular edema (DME). Specifically, this data came from the Phase 2 clinical trial (TYBEE) evaluating suprachoroidal CLS-TA used with intravitreally administered Eylea (aflibercept).

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares fell 17.8 percent to $11.95 in pre-market trading. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    CRISPR Therapeutics AG (NASDAQ: CRSP) fell 15.8 percent to $62.00 in pre-market trading after the company disclosed that the FDA has placed a clinical hold on IND for CTX001 sickle cell disease treatment.
    Sears Holdings Corporation (NASDAQ: SHLD) fell 10 percent to $2.89 in pre-market trading after the company posted a loss for the first quarter and announced plans to close 72 non-profitable stores.
    Urban One, Inc. (NASDAQ: UONE) fell 9 percent to $3.01 in pre-market trading after rising 78.38 percent on Wednesday.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares fell 8.6 percent to $88.05 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Ciena Corporation (NYSE: CIEN) fell 8.5 percent to $22.02 in the pre-market trading session after the company posted downbeat Q1 earnings and announced plans to buy Packet Design.
    Dollar General Corporation (NYSE: DG) shares fell 6.6 percent to $90.11 in pre-market trading after reporting weaker-than-expected results for its first quarter.
    Vericel Corp (NASDAQ: VCEL) shares fell 6.5 percent to $13.05 in pre-market trading following announcement of 3.75 million share common stock offering.
    Box, Inc. (NYSE: BOX) fell 5.7 percent to $26.19 in pre-market trading. Box reported upbeat results for its first quarter. The company forecast Q2 revenue of $146 million to $147 million.
    Co-Diagnostics, Inc. (NASDAQ: CODX) fell 5.7 percent to $3.15 in pre-market trading after declining 5.65 percent on Wednesday.
    Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) shares fell 5.2 percent to $18.21 in pre-market trading after reporting a 2

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (NASDAQ: CLSD) and Bluebird Bio (NASDAQ … (analystratings.com) Catabasis launches public equity offering (seekingalpha.com) Friedreich Ataxia Market Pipeline Therapeutics 2018 Top Key Players, Drug Profile and Product Description (thecleantechnology.com) Cellectis SA Receives a Buy from Oppenheimer (analystratings.com) Global Type I Hyperlipoproteinemia Drug Market 2018- Catabasis Pharmaceuticals, Inc., uniQure NV , Isis … (afinancialanalysis.com)

    Shares of Catabasis Pharmaceuticals traded down $0.28, reaching $1.06, on Monday, Marketbeat reports. The company’s stock had a trading volume of 2,344,684 shares, compared to its average volume of 645,019. The firm has a market cap of $38.91 million, a price-to-earnings ratio of -0.84 and a beta of 0.74. Catabasis Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $3.78.

  • [By Ethan Ryder]

    Shares of Clearside Biomedical Inc (NASDAQ:CLSD) have earned a consensus recommendation of “Buy” from the ten brokerages that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $22.40.

Top 10 Value Stocks To Buy For 2019: Bassett Furniture Industries Incorporated(BSET)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about Bassett Furniture Industries (NASDAQ:BSET) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Bassett Furniture Industries earned a news impact score of 0.08 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.0883846805754 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Value Stocks To Buy For 2019: Eaton Vance Short Diversified Income Fund(EVG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    EATON VANCE SHO/COM (NYSE:EVG) declared a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Investors of record on Friday, September 21st will be paid a dividend of 0.065 per share on Friday, September 28th. This represents a $0.78 dividend on an annualized basis and a yield of 6.06%. The ex-dividend date is Thursday, September 20th.

Leave a Reply

Your email address will not be published. Required fields are marked *